水凝和纳米凝:开拓先进药物输送系统的未来
Ernesto J Delgado-Pujol1,2, Guillermo Martínez1, David Casado-Jurado1,3
1Departamento de Química Orgánica y Farmacéutica, Facultad de Farmacia, Universidad de Sevilla, 41012 Sevilla, Spain.
Pharmaceutics
|February 26, 2025
概括
水凝和纳米凝提供先进的药物输送解决方案,通过提高生物可用性和患者的坚持来克服传统方法的局限性. 这些智能材料使下一代治疗药物的控制,有针对性的释放成为可能.
科学领域:
- 生物材料科学 生物材料科学
- 药物输送系统 药物输送系统
- 纳米技术 纳米技术
背景情况:
- 传统的药物输送面临着低生物可用性和患者不良坚持的挑战.
- 先进的药物输送系统 (DDS) 对于克服这些局限性至关重要.
- 水凝和纳米凝作为先进的DDS材料显示出显著的前景.
研究的目的:
- 审查水凝和纳米凝的演变,特性和分类.
- 探索它们在药物输送中的应用,包括合成和药物加载机制.
- 讨论基于水凝和纳米凝的DDS的挑战和未来战略.
主要方法:
- 对药物输送中的水凝和纳米凝现有文献的审查.
- 合成方法的分析 (化学交叉连接,物理自组装,微流体学,3D打印).
- 检查药物加载和释放策略 (封装,扩散,刺激反应,酶触发).
主要成果:
- 水凝和纳米凝提供了改善的药物稳定性,持续释放和高特异性.
- 这些材料可以适应各种管理途径 (局部,口服,注射).
- 纳米凝通过纳米级精度和刺激响应性提供了增强的治疗向.
结论:
- 水凝和纳米凝代表了个性化医学的变革潜力.
- 挑战包括可扩展的制造,监管批准和有针对性的交付优化.
- 未来的研究方向包括生物传感器,双刺激响应系统,以及用于增强特异性的表面功能化.
相关概念视频
Modified-Release Drug Delivery Systems: Rate-Programmed II
Rate-programmed drug delivery systems release drugs in a controlled manner to maintain therapeutic levels. Three main designs include reservoir, matrix, and hybrid systems.Reservoir systems consist of a drug core enclosed within a membrane that controls drug release. In non-swelling reservoir systems, polymers like ethyl cellulose or polymethacrylates are used. These do not hydrate in aqueous media and control release through membrane thickness, porosity, or insolubility. This type includes...
Site-Targeted Drug Delivery Systems: Polymeric Carriers
Polymeric carriers enhance targeted drug delivery by increasing efficacy while minimizing off-target effects. These carriers comprise a biodegradable polymeric backbone integrated with functional elements that enable targeting, improve physicochemical properties, and regulate drug release.Targeting MechanismsThe targeting ability of polymeric carriers is mediated by a homing device, which is a molecular recognition component designed to selectively bind to specific tissues or cells. Monoclonal...
Drug Delivery Systems: Different Types
Conventional oral drug products, termed immediate-release (IR) formulations, are engineered to promptly release their active pharmaceutical ingredient (API) upon ingestion, typically in tablets or capsules. This rapid release often results in swift drug absorption and consequent pharmacodynamic effects, although the timing and intensity can vary depending on the drug's properties. Prodrugs within these formulations require metabolic conversion to activate their pharmacodynamic effects,...
Modified-Release Drug Delivery Systems: Stimuli-Activated
Stimuli-activated drug delivery systems are designed to release drugs in response to specific physical, chemical, or biological stimuli. These systems often utilize hydrogels—three-dimensional, hydrophilic polymer networks capable of swelling in aqueous environments and retaining significant fluid volumes. Upon exposure to particular stimuli, these hydrogels undergo structural transitions that allow the embedded drug to be released. Due to this adaptive behavior, such systems are also called...
Drug Delivery: Overview
The selection of a drug's delivery route depends upon its physicochemical properties, including lipid or water solubility and ionization, as well as the therapeutic requirement, such as immediate or sustained effect. These routes can be divided into three primary categories: enteral, parenteral, and topical.
Enteral delivery involves administering drugs directly through swallowing, sublingual placement, or buccal application. Orally administered drugs predominantly navigate the gastrointestinal...
Enteral delivery involves administering drugs directly through swallowing, sublingual placement, or buccal application. Orally administered drugs predominantly navigate the gastrointestinal...


